Literature DB >> 6279634

The mechanism of the insulin-like effects of ionic zinc.

J M May, C S Contoreggi.   

Abstract

The insulin-like effects of ionic zinc (Zn2+) were studied in isolated rat adipocytes. Concentrations of Zn2+ between 250 and 1000 microM stimulated 3-O-methylglucose transport and glucose metabolism to CO2, glyceride-fatty acid, and glyceride-glycerol. Selective stimulation of the pentose phosphate cycle was observed since a Zn2+-induced increase in glucose carbon 1 oxidation persisted even when glucose transport was blocked with 50 microM cytochalasin B or when transport was no longer rate-limiting for metabolism at high concentrations of glucose. Enhanced pentose phosphate cycle activity may have been due to a selective inhibition of glutathione reductase by the ion, which was also accompanied by a fall in cellular glutathione content. Zn2+ also inhibited lipolysis stimulated by the beta-adrenergic agent ritodrine in the absence of glucose. The effects of Zn2+ on glucose oxidation and stimulated rates of lipolysis were inhibited by extracellular catalase, indicating that they were largely a result of H2O2 generation. The H2O2 production appeared for the most part to be caused by zinc-catalyzed autoxidation of sulfhydryl groups present on external cell membranes, although involvement of sulfhydryl groups on bovine serum albumin in the buffer could also have contributed. The insulin-like effects of Zn2+ in adipocytes are therefore caused not only by direct effects of the ion on intracellular metabolism but also by indirect effects related to H2O2 generation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6279634

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Parenteral zinc and tissue metallothionein in normal and diabetic rats.

Authors:  L Y Lin; C C McCormick
Journal:  Biol Trace Elem Res       Date:  1986-12       Impact factor: 3.738

Review 2.  Zinc homeostasis in the metabolic syndrome and diabetes.

Authors:  Xiao Miao; Weixia Sun; Yaowen Fu; Lining Miao; Lu Cai
Journal:  Front Med       Date:  2013-02-06       Impact factor: 4.592

3.  Cadmium-induced stimulation of lipogenesis from glucose in rat adipocytes.

Authors:  A Yamamoto; O Wada; T Ono; H Ono; S Manabe; S Ishikawa
Journal:  Biochem J       Date:  1984-05-01       Impact factor: 3.857

4.  Cell-type-specific roles of IGF-1R and EGFR in mediating Zn2+-induced ERK1/2 and PKB phosphorylation.

Authors:  Nihar R Pandey; George Vardatsikos; Mohamad Z Mehdi; Ashok K Srivastava
Journal:  J Biol Inorg Chem       Date:  2009-11-28       Impact factor: 3.358

5.  Phenylalaninylargininylarginine: a novel tripeptide exerting Zn(2+)-dependent, insulin-mimetic inhibitory action on myocardial proteolysis.

Authors:  L Zhang; T D Lockwood
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

Review 6.  Zinc and insulin sensitivity.

Authors:  P Faure; A Roussel; C Coudray; M J Richard; S Halimi; A Favier
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

7.  Effect of acute zinc deficiency on insulin receptor binding in rat adipocytes.

Authors:  M J Gomot; P Faure; A M Roussel; C Coudray; M Osman; A Favier
Journal:  Biol Trace Elem Res       Date:  1992 Jan-Mar       Impact factor: 3.738

8.  A new insulin-mimetic bis(allixinato)zinc(II) complex: structure-activity relationship of zinc(II) complexes.

Authors:  Yusuke Adachi; Jiro Yoshida; Yukihiro Kodera; Akira Kato; Yutaka Yoshikawa; Yoshitane Kojima; Hiromu Sakurai
Journal:  J Biol Inorg Chem       Date:  2004-09-18       Impact factor: 3.358

9.  Zinc transporter Slc39a14 regulates inflammatory signaling associated with hypertrophic adiposity.

Authors:  Catalina Troche; Tolunay Beker Aydemir; Robert J Cousins
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-12-08       Impact factor: 4.310

10.  The effect of selenium-deficiency on rat fat-cell glucose oxidation.

Authors:  J E Souness; J E Stouffer; V Chagoya de Sanchez
Journal:  Biochem J       Date:  1983-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.